$BBUC

3 stories mentioning BBUCUpdated just now

Every FINWIRES story that references BBUC, newest first.

Sector Update: Financial Stocks Edge Higher Pre-Bell Thursday

Financial stocks were edging higher pre-bell Thursday, with the State Street Financial Select Sector SPDR ETF (XLF) advancing by 0.5%.The Direxion Daily Financial Bull 3X Shares (FAS) was up 1.8% and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was 1.7% lower.Morgan Stanley (MS) stands to benefit from the planned initial public offering of the National Stock Exchange of India, Bloomberg reported. Shares of Morgan Stanley were up 1.1% premarket.Brookfield Business (BBUC) has agreed to sell its Multiplex Global subsidiary to Obayashi, the Japanese company said. Brookfield Business stock was up more than 2% pre-bell.HSBC (HSBC) has been ordered by Australia's Federal Court to pay a 35 million Australian dollar ($24.6 million) penalty after admitting to serious failures in protecting customers from scams, Australian Securities and Investments Commission said. HSBC stock was marginally lower premarket.

$BBUC$FAS$FAZ$HSBC$MS$XLF

Research9d ago

TD Cowen Initiates Brookfield Business at Hold With $34 Price Target

Brookfield Business (BBUC) has an average rating of overweight and mean price target of $39.93, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BBUC

Wire38d ago

Brookfield Business Shares Fell After Q1 Results Reflecting CDK, Sagen Pressures, RBC Says

Brookfield Business' (BBUC) shares fell after Q1 results, mainly due to concerns around CDK Global experiencing challenges and Sagen seeing an increase in its loss ratio, RBC Dominion Securities said in a note Monday."CDK has not been immune to AI/software-related challenges, with the company's first lien notes trading at distressed levels," the analysts said, adding that Brookfield Business is focused on recovering its investment, and CDK is estimated to represent less than 10% of the company's net asset value, or NAV. The 8% post-earnings drop in Brookfield Business shares partially reflects market concerns that CDK equity may be worth nothing, the analysts added.The analysts said Sagen's higher loss ratio, which represents about 15% of Brookfield Business' NAV, is "manageable." Its Q1 loss ratio rose to 12% from 5% in 2025 and above the prior four-year average of 5%, with Sagen expecting it to remain around 12% in 2026.The analysts said that they believe Brookfield Business' track record of investment performance, driven by a differentiated strategy and capital deployment over the past several years in a favorable investment environment, could support strong NAV growth going forward.RBC lowered its price target on Brookfield Business to $40 from $44 and reiterated its outperform rating.Price: $31.18, Change: $+0.32, Percent Change: +1.05%

$BBUC

Track with the FINWIRES app suite

FolioX

Track BBUC in your portfolio

WheelAI

Analyze BBUC options with the wheel strategy

StockInsider

See market sentiment on BBUC